A Study to Assess Growth in Children With Idiopathic Short Stature
A Multicenter, Observational Study to Characterize Growth in Children With Idiopathic Short Stature
1 other identifier
observational
300
1 country
40
Brief Summary
Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
Longer than P75 for all trials
40 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2024
CompletedFirst Posted
Study publicly available on registry
March 13, 2024
CompletedStudy Start
First participant enrolled
August 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2040
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2040
November 14, 2025
November 1, 2025
16.4 years
March 7, 2024
November 13, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Change in annualized growth velocity (AGV)
Every 6 months through end of study, up to 15 years
Change in Height Z-score
Every 6 months through end of study, up to 15 years
Change in Standing Height
Every 6 months through end of study, up to 15 years
Change in BMI
Every 6 months through end of study, up to 15 years
Change in BMI Z-score
Every 6 months through end of study, up to 15 years
Secondary Outcomes (4)
Frequency of event rates of medical events of interest
Every 6 months through end of study, up to 15 years
Frequency of Serious Medical Events
Every 6 months through end of study, up to 15 years
Association between specific variants and growth velocity
Every 6 months through end of study, up to 15 years
Association between other health outcomes directly related to short stature
Every 6 months through end of study, up to 15 years
Eligibility Criteria
The study population will include up to 600 pediatric individuals with Idiopathic Short Stature.
You may qualify if:
- Participants must be \> 2 years old, and ≤ 14 years old (female) or ≤ 16 years old (males) at the time of signing the informed consent.
- A height assessment corresponding to a height Z-score of ≤ -2.25 SDs in reference to the general population of the same age and sex, as calculated using the Centers for Disease Control and Prevention (CDC) growth chart (https://www.cdc.gov/growthcharts/zscore.htm).
- Participants who have either never received hGH, or who are currently receiving hGH treatment.
- Historic stimulation test result with serum or plasma GH level greater than 10 μg/L.
- Parent(s) or guardian(s) are willing and able to provide written, signed informed consent.
You may not qualify if:
- Known presence of one or more pituitary hormone deficiencies
- Bone age advanced over chronological age by more than 3 years.
- For hGH naïve participants, historic stimulation test result with serum or plasma GH level greater than 10 μg/L or serum IGF-1 in the normal range for age (between -1.00 SDs and +2.00 SDs).
- For participants currently on hGH treatment, historic results before GH treatment of stimulation test with serum or plasma GH level greater than 10 μg/L or serum IGF-1 test between -1.00 SDs and +2.00 SDs.
- Have received an investigational product (IP) or investigational medical device for any purpose within 6 months before the Screening visit. .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (40)
Phoenix Children's Hospital - Thomas Campus (Main)
Phoenix, Arizona, 85016, United States
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed)
Los Angeles, California, 90502, United States
Children's Hospital of Orange County Main Campus - Orange
Orange, California, 92868, United States
Center Of Excellence in Diabetes and Endocrinology
Sacramento, California, 95821, United States
Rady Children's Hospital - San Diego
San Diego, California, 92123, United States
University of California San Francisco (UCSF)
San Francisco, California, 94143, United States
Connecticut Children's Medical Center
Hartford, Connecticut, 06106-3322, United States
Yale School of Medicine
New Haven, Connecticut, 06511, United States
Children's National Health System
Washington D.C., District of Columbia, 20010, United States
Nemours Children's Clinic
Jacksonville, Florida, 32207, United States
Nicklaus Children's Hospital
Miami, Florida, 33155, United States
Nemours Children's Health System - Corporate Headquarters
Pensacola, Florida, 32514, United States
Centricity Research
Columbus, Georgia, 31904, United States
St. Luke's Children's Endocrinology
Boise, Idaho, 83712, United States
Rocky Mountain Diabetes Center - Idaho Falls
Idaho Falls, Idaho, 83404-7596, United States
Rocky Mountain Clinical Research - Idaho Falls
Idaho Falls, Idaho, 83404, United States
University of Louisville School Of Medicine - Norton Children's Hospital
Louisville, Kentucky, 40202, United States
Ochsner Health Center for Children - New Orleans
New Orleans, Louisiana, 70121, United States
University of Michigan
Ann Arbor, Michigan, 48109-4000, United States
University of Minnesota Medical School - Masonic Children's Hospital - Pediatric Specialty Care Explorer Clinic
Minneapolis, Minnesota, 55454, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
University of Iowa Stead Family Children's Hospital
Princeton, New Jersey, 08540, United States
UBMD Pediatrics
Buffalo, New York, 14203, United States
ACGC Research, NYU Ambulatory Care Garden City
Garden City, New York, 11530, United States
New York University Grossman School of Medicine
New York, New York, 10016, United States
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) - Pediatric Associates
New York, New York, 10029, United States
Montefiore Medical Center (MMC) - The Children's Hospital at Montefiore (CHAM)
The Bronx, New York, 10467, United States
WakeMed Children's - Pediatric Endocrinology - North Raleigh
Raleigh, North Carolina, 27615, United States
Cincinnati Children's Hospital Medical Center Burnet Campus
Cincinnati, Ohio, 45229, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Prisma Health Children's Hospital - Midlands
Columbia, South Carolina, 29203, United States
Vanderbilt University Medical Center
Nashville, Tennessee, 37232-2578, United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Cook Children's Endocrinology
Fort Worth, Texas, 76104, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Charleston Area Medical Center (CAMC) Health System
Charleston, West Virginia, 25304, United States
Charleston Area Medical Center (CAMC) Health System
Charleston, West Virginia, 25304, United States
Medical College of Wisconsin, Children's Hospital
Milwaukee, Wisconsin, 53226, United States
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2024
First Posted
March 13, 2024
Study Start
August 8, 2024
Primary Completion (Estimated)
December 31, 2040
Study Completion (Estimated)
December 31, 2040
Last Updated
November 14, 2025
Record last verified: 2025-11